REGENXBIO2019-10-20T21:22:30+00:00
REGENXBIO

REGENXBIO

REGENXBIO (NASDAQ: RGNX) is a gene therapy platform company that is leveraging its proprietary NAV® Technology to advance the development of life-changing adeno-associated viral (AAV) treatments for lysosomal storage disorders, ocular diseases, and other unmet clinical needs.

Zai Lab2019-10-21T12:25:26+00:00
Zai Lab

Zai Lab

Zai Lab is a Shanghai-based biopharmaceutical company. Our globally-experienced drug development team is passionate about bringing transformative medicines to China and discovering and developing our own therapeutics for patients worldwide.